Oct 29 (Reuters) - Teladoc Health Q3 adjusted EBITDA USD 69.909 million vs. IBES estimate USD 65.9 million.
Q3 basic EPS USD -0.28
Q3 net income USD -49.507 million
Q3 revenue USD 626.439 million vs. IBES estimate USD 626 million
outlook FY revenue USD 2,510-2,539 million
outlook FY EPS USD -1.25 to -1.1
outlook FY adjusted EBITDA USD 270-287 million
outlook Q4 revenue USD 622-652 million
outlook Q4 EPS USD -0.25 to -0.1
outlook Q4 adjusted EBITDA USD 73-90 million
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.